Irritable bowel syndrome (IBS) is one of the most common functional gastro-intestinal
disorders which significantly impacts the quality of life of affected children. Abdominal pain improved
by defecation, associated with a change in stool form and frequency, represents its specific
clinical marker. Even if a number of potential patho-physiological mechanisms have been described,
the exact underlying etiology of IBS is so far unclear. Likewise, no optimal treatment has
ever been found neither for adult nor for pediatric patients. Current therapeutic options include
drugs, dietary interventions and biopsychosocial therapies. The present review aims at evaluating
the scientific evidence supporting the efficacy of these treatments for children with IBS.
Keywords: Scientific evidence, irritable, bowel syndrome, IBS, biopsychosocial therapies, gastro-intestinal disorders.
Rights & PermissionsPrintExport